zoledronic acid has been researched along with Squamous Cell Carcinoma of Head and Neck in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billhymer, A; Lundberg, AP; Selting, KA; Tran Hoang, C | 1 |
| Kang, MK; Kim, RH; Lee, SH; Martin, CE; Nguyen, A; Park, NH; Rigas, N; Shin, KH | 1 |
| Barbai, T; Cserepes, M; Dobos, J; Hegedűs, Z; Kárpáti, A; Kenessey, I; László, V; Nelhűbel, GA; Őrfi, L; Rásó, E; Szabó, B; Szokol, B; Tóvári, J; Türk, D | 1 |
| Arai, N; Hattori, Y; Inoue, S; Noguchi, M; Takashina, M; Tomihara, K | 1 |
4 other study(ies) available for zoledronic acid and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Combining radiation therapy with zoledronate for the treatment of osteo-invasive feline oral squamous cell carcinoma.
Topics: Animals; Bone Density Conservation Agents; Carcinoma, Squamous Cell; Cat Diseases; Cats; Diphosphonates; Head and Neck Neoplasms; Mouth Neoplasms; Osteolysis; Quality of Life; Squamous Cell Carcinoma of Head and Neck; Zoledronic Acid | 2022 |
Zoledronic acid impairs oral cancer stem cells by reducing CCL3.
Topics: Cell Line, Tumor; Chemokine CCL3; Humans; Mouth Neoplasms; Neoplastic Stem Cells; Squamous Cell Carcinoma of Head and Neck; Zoledronic Acid | 2021 |
EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Indoles; Mice; Mice, SCID; Mutation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Squamous Cell Carcinoma of Head and Neck; Sulfonamides; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zoledronic Acid | 2021 |
Extracellular Ca(2+)-dependent enhancement of cytocidal potency of zoledronic acid in human oral cancer cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Calcium; Calcium Chelating Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cytochromes c; Diphosphonates; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Imidazoles; MCF-7 Cells; Membrane Potential, Mitochondrial; Mitochondria; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Zoledronic Acid | 2015 |